National Chemotherapy Advisory Group report: implications for nurses
Elaine Lennan Vice-chair, UKONS Chemotherapy Nurses Forum, Southampton University Hospitals NHS Trust, Southampton
Helen Roe Chair, UKONS Chemotherapy Nurses Forum, North Cumbria University Hospitals NHS Trust, North Cumbria
Annie Young Former UKONS president, and acting director, 3 Counties Cancer Network, Gloucester
Maggie Crowe UKONS president, and development manager, Macmillan Cancer Support, Crown Chambers, Hampshire
As a group of senior cancer nurses, the UK Oncology Nursing Society (UKONS) Board welcomes the recommendations from the National Chemotherapy Advisory Group report, believing that it will improve the services offered to patients and strengthen the leadership role of nurses who work in cancer care. This article explains the key tenets of the report from a nursing perspective and considers the effect it will have on chemotherapy services and on the profession as a whole.
Nursing Standard. 24, 36,35-40. doi: 10.7748/ns2010.05.24.36.35.c7773Correspondence
This article has been subject to double blind peer review